{"id":"https://openalex.org/W4308397175","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0855","title":"855 Diacylglycerol kinase alpha and zeta dual inhibitors enhance T cell responses and promote robust and durable anti-tumor T cell immunity","display_name":"855 Diacylglycerol kinase alpha and zeta dual inhibitors enhance T cell responses and promote robust and durable anti-tumor T cell immunity","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308397175","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0855"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0855","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0855","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0855","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A894.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A894.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004476251","display_name":"Marcos W. Steinberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcos Steinberg","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037737253","display_name":"Darina S. Spasova","orcid":"https://orcid.org/0000-0002-4334-5231","observed_orcids":["https://orcid.org/0000-0002-4334-5231"]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darina Spasova","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071470426","display_name":"Danelle S. Eto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danelle Eto","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053061201","display_name":"AnneMarie Culazzo Pferdekamper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"AnneMarie Pferdekamper","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Phuong Nguyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phuong Nguyen","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100564302","display_name":"Brian Le","orcid":"https://orcid.org/0009-0008-0913-460X","observed_orcids":["https://orcid.org/0009-0008-0913-460X"]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Le","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010979438","display_name":"Zachary Naiman","orcid":"https://orcid.org/0000-0001-8359-1990","observed_orcids":["https://orcid.org/0000-0001-8359-1990"]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary Naiman","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110945383","display_name":"Susan Murphy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Murphy","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109134649","display_name":"Maricel C. Gozo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maricel Gozo","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":null,"display_name":"James Skipper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Skipper","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013083711","display_name":"Taylor Ismaili","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taylor Ismaili","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101488371","display_name":"Xikui Liu","orcid":"https://orcid.org/0000-0002-4509-9468","observed_orcids":["https://orcid.org/0000-0002-4509-9468"]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xikui Liu","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050157570","display_name":"Sunil Sahdeo","orcid":"https://orcid.org/0000-0001-6355-0163","observed_orcids":["https://orcid.org/0000-0001-6355-0163"]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sunil Sahdeo","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008596951","display_name":"Xiao Hu","orcid":"https://orcid.org/0000-0002-3737-7958","observed_orcids":["https://orcid.org/0000-0002-3737-7958"]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiao Hu","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050461456","display_name":"Isharat Yusuf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Isharat Yusuf","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038297657","display_name":"Kristen Taylor Meadows","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristen Taylor Meadows","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040898659","display_name":"Laura Carter","orcid":"https://orcid.org/0000-0003-3589-6225","observed_orcids":["https://orcid.org/0000-0003-3589-6225"]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Carter","raw_affiliation_strings":["Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210111220"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A894","last_page":"A894"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.6395999789237976,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.6395999789237976,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.2045000046491623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.10419999808073044,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diacylglycerol-kinase-zeta","display_name":"diacylglycerol kinase zeta","score":0.9980000257492065},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.9210000038146973},{"id":"https://openalex.org/keywords/anti-pd-1-combination-therapy","display_name":"anti-PD-1 combination therapy","score":0.8090000152587891},{"id":"https://openalex.org/keywords/mc38-tumor-model","display_name":"MC38 tumor","score":0.6480000019073486},{"id":"https://openalex.org/keywords/lcmv-clone-13","display_name":"LCMV clone 13","score":0.7900000214576721},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.6449999809265137},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.5899999737739563},{"id":"https://openalex.org/keywords/tumor-rechallenge","display_name":"tumor rechallenge","score":0.4050000011920929},{"id":"https://openalex.org/keywords/adenosine","display_name":"adenosine","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C36020004","wikidata":"https://www.wikidata.org/wiki/Q106951674","display_name":"Diacylglycerol kinase","level":4,"score":0.6828637719154358},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.6646242737770081},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.47996973991394043},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42794597148895264},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.40727540850639343},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3649875521659851},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.23960521817207336},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23718595504760742},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23598161339759827},{"id":"https://openalex.org/C195794163","wikidata":"https://www.wikidata.org/wiki/Q420877","display_name":"Protein kinase C","level":3,"score":0.14235377311706543}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2022-sitc2022.0855","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0855","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0855","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A894.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0855","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0855","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0855","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A894.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308397175.pdf","grobid_xml":"https://content.openalex.org/works/W4308397175.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W2035756665","https://openalex.org/W2054467922","https://openalex.org/W2102741019","https://openalex.org/W4239239124"],"related_works":["https://openalex.org/W4404064541","https://openalex.org/W7148267483","https://openalex.org/W4388048471","https://openalex.org/W3191401694","https://openalex.org/W2955717207","https://openalex.org/W4409628765","https://openalex.org/W2531003619","https://openalex.org/W4388966812","https://openalex.org/W2789903971","https://openalex.org/W4308400762"],"abstract_inverted_index":{"Background":[0],"Diacylglycerol":[1,400],"kinases":[2,419],"(DGK)":[3],"convert":[4],"diacylglycerol":[5,418,449,472],"(DAG)":[6],"into":[7],"phosphatidic":[8],"acid":[9],"which":[10],"limits":[11],"DAG-induced":[12],"propagation":[13],"of":[14,31,53,58,75,91,111,144,180,214,228,233,272,405,417,441,505,537],"T":[15,18,34,45,67,85,94,103,120,124,131,150,183,190,203,236,249,260,279,328,335,348,372,421,442,480,509],"cell":[16,35,68,86,95,121,125,151,191,250,280,329,336,343,349,373,406,422,443,481],"activation.1":[17],"cells":[19,46,132,184,204,217,237,261,312,510],"predominantly":[20],"express":[21],"DGK":[22,25],"alpha":[23,451],"and":[24,29,37,47,101,118,161,193,225,247,345,369,424,445,452,477,499,528],"zeta":[26],"isoforms":[27,188],"(DGKalpha/zeta),2":[28],"deletion":[30],"either":[32],"enhances":[33,83,346,474],"activation":[36,96,152,192,281,476],"function.3,4":[38],"DGKalpha/zeta":[39,59,76,80,92,181,325,332,379],"are":[40],"overexpressed":[41],"in":[42,93,130,153,167,275,278,282,286,293,301,359,381,420,530],"tumor":[43,171,230,299,340,446],"infiltrating":[44],"may":[48],"limit":[49],"the":[50,109,168,178,207,294,403,533],"anti-tumor":[51,69,84,318,367],"activity":[52,143],"these":[54],"cells.5":[55],"Thus,":[56],"inhibition":[57,74,333,380],"is":[60,512],"a":[61,387],"potential":[62],"therapeutic":[63,388],"avenue":[64],"to":[65,222,338],"enhance":[66],"responses.":[70,320,483],"We":[71,322],"demonstrate":[72,323],"that":[73,186,324,357,511],"with":[77,157,206,218,238,252,288,297,310,361,383,532],"novel":[78],"dual":[79,378],"inhibitors":[81],"(DGKi)":[82],"activity.":[87,330,351],"Methods":[88],"The":[89],"role":[90,179],"was":[97,146,291],"studied":[98],"using":[99,115],"wildtype":[100],"CRISPR-knockout":[102],"cells.":[104,231],"In":[105,141,352],"vitro":[106],"studies":[107,127,160,176,525],"assessing":[108],"effect":[110],"DGKi":[112,145,195,219,239,255,273,285,358],"were":[113,128,165,526],"conducted":[114,529],"various":[116],"mouse":[117,215],"human":[119,201,506],"functional":[122,482],"assays.":[123],"exhaustion":[126,241],"performed":[129,166],"from":[133,259],"lymphocytic":[134],"choriomeningitis":[135],"virus":[136],"(LCMV)":[137],"clone":[138],"13-infected":[139],"mice.":[140,283],"vivo":[142,353],"assessed":[147],"by":[148,200,243,263,448,514],"measuring":[149],"OT-I":[154,216],"mice":[155,305],"challenged":[156],"OVA-peptides.":[158],"Efficacy":[159],"memory":[162,319],"rechallenge":[163,309],"experiments":[164],"MC38":[169,295,311],"syngeneic":[170],"model.":[172],"Results":[173],"CRISPR":[174],"knockout":[175],"characterizing":[177],"on":[182],"demonstrated":[185],"both":[187],"regulate":[189],"function.":[194,425],"enhanced":[196,220,248],"IFN":[197],"gamma":[198],"production":[199],"melanoma-specific":[202],"stimulated":[205],"weak":[208,339],"affinity":[209],"MART1":[210],"antigen.":[211],"Similarly,":[212],"treatment":[213],"responses":[221,337,368],"low-affinity":[223],"OVA-peptides":[224],"OT-I-mediated":[226],"cytotoxicity":[227],"MC38-OVA":[229],"Treatment":[232],"exhausted":[234],"CD8":[235,347],"reverted":[240],"caused":[242],"chronic":[244],"LCMV":[245],"infection,":[246],"function":[251],"PDL1":[253],"blockade.":[254],"rescued":[256],"cytokine":[257],"release":[258],"suppressed":[262],"adenosine,":[264],"TGF":[265],"beta":[266],"or":[267],"PGE2":[268],"treatment.":[269,392],"Oral":[270],"administration":[271],"resulted":[274],"dose-dependent":[276],"increase":[277],"Furthermore,":[284],"combination":[287,360,382],"anti-PD-1":[289,362,384],"therapy":[290,364],"efficacious":[292],"model":[296],"complete":[298],"regressions":[300],"treated":[302],"animals.":[303],"These":[304,375],"eradicated":[306],"tumors":[307],"upon":[308],"two":[313],"months":[314],"later,":[315],"demonstrating":[316],"durable":[317,371],"Conclusions":[321],"negatively":[326],"regulates":[327],"Dual":[331],"restores":[334],"antigens,":[341],"overcomes":[342],"exhaustion,":[344],"cytotoxic":[350],"efficacy":[354],"data":[355,376],"demonstrates":[356],"antibody":[363],"promotes":[365],"robust":[366],"generates":[370],"memory.":[374],"support":[377],"antibodies":[385],"as":[386],"approach":[389],"for":[390],"cancer":[391],"References":[393],"M\u00e9rida":[394],"I,":[395,494],"Avila-Flores":[396],"A,":[397],"Merino":[398],"E.":[399],"kinases:":[401],"at":[402],"hub":[404],"signalling.":[407],"Biochem":[408],"J.":[409],"2008;":[410,461],"409(1):1\u201318.":[411],"Krishna":[412],"S,":[413],"Zhong":[414],"X.":[415],"Role":[416],"development":[423,444],"Crit":[426],"Rev":[427],"Immunol.":[428,518],"2013;":[429],"33(2):97\u2013118.":[430],"Guo":[431],"R,":[432],"Wan":[433],"C-K,":[434],"Carpenter":[435],"JH,":[436],"et":[437,469,495],"al.":[438,470,496],"Synergistic":[439],"control":[440],"suppression":[447],"kinase":[450],"zeta.":[453],"Proc":[454],"Natl":[455],"Acad":[456],"Sci":[457],"U":[458],"S":[459],"A.":[460],"105(33):11909\u201314.":[462],"Riese":[463],"MJ,":[464],"Grewal":[465],"J,":[466,468],"Das":[467],"Decreased":[471],"metabolism":[473],"ERK":[475],"augments":[478],"CD8+":[479,508],"J":[484,517],"Biol":[485],"Chem.":[486],"2011;":[487],"286(7):5254\u201365.":[488],"Prinz":[489],"PU,":[490],"Mendler":[491],"AN,":[492],"Masouris":[493],"High":[497],"DGK-\u03b1":[498],"disabled":[500],"MAPK":[501],"pathways":[502],"cause":[503],"dysfunction":[504],"tumor-infiltrating":[507],"reversible":[513],"pharmacologic":[515],"intervention.":[516],"2012;":[519],"188(12):5990\u20136000.":[520],"Ethics":[521],"Approval":[522],"All":[523],"animal":[524],"approved":[527],"accordance":[531],"Explora":[534],"IACUC":[535],"Program":[536],"Veterinary":[538],"Care.":[539]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2022-11-11T00:00:00"}